Main
Marine sponges of the order Verongida are characterized by their ability to synthesize brominated tyrosine derivatives, many of which possess potent anti-microbial and cytotoxic activities.1 Purealin,2, 3, 4 Lipopurealin A–E,5, 6 Purealidin A–S,6, 7, 8, 9, 10, 11 Psammaplysin A–B,12 Purpuramine A–J,11, 13 Aplysamines 2–514 and Macrocyclic peptides Bastadins15 isolated from Verongida have been previously reported as brominated tyrosine derivatives. The diverse modification of these biosynthetically related compounds occurs in both the side chain and aromatic ring of the brominated tyrosine precursors. It has been reported that many brominated tyrosine derivatives were isolated from Verongida, Psammaplysilla purpurea;1, 2, 5, 6, 7, 8, 9, 10, 13, 14, 15 therefore, P. purpurea is a potential resource for the chemical screening of novel compounds. We thus attempted to isolate new compounds from P. purpurea, and resulted in the isolation of a new compound designated as JBIR-44 (1) (Figure 1). In this paper, we report the isolation, structure elucidation and brief biological activity of 1.
P. purpurea (class, Demospongiae; order, Verongida; family, Aplysinellidae) was collected at a depth of −25 m from Kinwan bay, Okinawa prefecture, Japan, in February 2007. P. purpurea (300 g, wet) was extracted with MeOH and, after concentration in vacuo, MeOH–H2O (3:7) was added to the aqueous concentrate. The MeOH–H2O solution (500 ml) was partitioned with EtOAc (three times). After drying over Na2SO4, the EtOAc layer was evaporated to dryness. The dried residue was subjected to normal-phase MPLC (Purif-Pack SI-60, Moritex, Tokyo, Japan) eluted with a Hexane-EtOAc (0–30% EtOAc) linear gradient system, followed by elution with a CHCl3–MeOH (0–90% MeOH) linear gradient system. The 10–30% MeOH elute fractions were further purified by reversed-phase HPLC using a PEGASIL ODS column (Senshu Pak, 20 i.d. × 150 mm, Senshu Scientific, Tokyo, Japan) with a H2O–MeOH (0–100% MeOH) linear gradient system containing 0.1% formic acid to yield JBIR-44 (1, 4.4 mg), together with four known compounds, purealidin C (2.1 mg),6 purpuramine F (1.8 mg),13 araplysillin I (45.3 mg)16 and aplysamine 4 (175 mg).14
Compound 1 was obtained as a colorless oil (UV (MeOH) λmax (ɛ) 283 (1700), 208 (17 600)). The electrospray ionization-mass spectrum (ESI-MS) displayed an isotopic cluster (640.9, 642.9, 644.9, 646.9, 648.9) that was consistent with the presence of four bromine atoms. Its molecular formula was established as C18H16Br4N2O4 (m/z [M+H]+ 640.7918, −0.4 mmu) by high-resolution ESI-MS. Compound 1 also displayed the IR spectrum [(KBr) vmax] at 3560, 3510, 3415, 1675 and 1630 cm−1.
The structure of 1 was elucidated as follows: The 1H and 13C NMR spectral data for 1 are shown in Table 1 and the structural information on 1 was further obtained by a series of 2D NMR analyses, such as heteronuclear single-quantum coherence, heteronuclear multiple-bond correlation (HMBC) and double-quantum-filtered correlation (DQF-COSY) spectra (Figure 2). Analyses of 1H-13C long-range couplings in the HMBC spectrum revealed two partial structures. In the HMBC spectrum, aromatic protons 1/5-H (δH 7.52) strongly m-coupled with each other and with an aromatic carbon C-3 (δC 152.0), which in turn long-range coupled to a methoxyl proton 3-OMe (δH 3.85, δC 61.0). A singlet methylene proton 7-H (δH 3.87) was long-range coupled to aromatic methine carbons C-1/5 (δC 134.4) and to an aromatic quaternary carbon C-6 (δC 137.3). Thus, the methylene carbon C-7 was deduced to be substituted at the position of C-6. The all assignment of this tetrasubstituted benzene ring moiety was established by 1H-13C long-range couplings as shown in Figure 2. These results revealed the presence of a 2,4-disubstituted-3-methoxy-phenylene moiety as shown in Figure 2. In the same manner, long-range couplings observed in the HMBC spectrum and the 13C chemical shift at C-15 (δC 150.7) revealed a 4-oxygenated 1,3,4,5-tetrasubstituted benzene moiety. A methylene proton 11-H (δH 2.73), which was spin coupled to a methylene proton 10-H (δH 3.45), was 1H-13C long-range coupled to aromatic methine carbons C-13/17 (δC 133.6) and to an aromatic quaternary carbon C-12 (δC 134.6). 1H-13C long-range couplings from the methylene proton 10-H to an amide carbonyl carbon C-9 (δC 165.4), from the methylene proton 7-H to a hydroxyimino carbon C-8 (δC 153.8) and to the amide carbonyl carbon C-9, together with IR absorptions assignable to an amide and an imino functional group (1655 and 1620 cm−1, respectively)11 revealed that two tetrasubstituted benzene substructures were connected through a 2-(hydroxyimino) acetamide moiety11 as shown in Figure 2. This structure was also supported by the 13C chemical shifts of the amide and imino carbons and IR absorptions observed in aplysamine 4.14 From the molecular formula of 1, four bromine atoms were determined to be substituted at the position of C-2, C-4, C-14 and C-16, and a remaining hydroxyl group was assigned to an oxime functional group at the imino moiety. The geometry of C-8 at oxime moiety was elucidated as E from the up-field 13C chemical shift of C-7 (δC 28.7) because of the γ-effect of the hydroxyl group of the oxime function. The different 13C chemical shifts between E (δC 27.5) and Z (δC 35.7) observed in (E,Z)-N,N′-Bis [3-(3′-bromo-4′-hydroxyphenyl)-2-oximidopropionyl] cystamine,17 of which positions corresponded to C-7 in 1, supported the stereochemistry at C-8.
The cytotoxic effects of 1 and aplysamine 4 against human cervical carcinoma HeLa cells were determined by WST-8 colorimetric assay (Dojindo, Kumamoto, Japan). HeLa cells were treated for 48 h with various concentrations of 1 and aplysamine 4, which showed the cytotoxic effects in a dose-dependent manner with the IC50 values of 3.7 and 3.4 μM, respectively. These results indicate that a 3-aminopropanol chain structure at C-15 does not affect cytotoxic activity. As 1 is a structurally interesting compound, it is expected to be a potential candidate for a novel anti-cancer drug targeting new molecules. Studies on detailed biological activities are now underway.
References
James, D. M., Kunze, H. B. & Faulkner, D. J. Two New Brominated Tyrosine Derivatives from the Sponge Druinella (=Psammaplysilla) purpurea. J. Nat. Prod. 54, 1137–1140 (1991).
Nakamura, H. et al. Purealin, a novel enzyme activator from the Okinawan marine sponge Psammaplysilla purea. Tetrahedron Lett. 26, 4517–4520 (1985).
Takito, J. et al. Purealin, a novel stabilizer of smooth muscle myosin filaments that modulates ATPase activity of dephosphorylated myosin. J. Biol. Chem. 261, 13861–13865 (1986).
Nakamura, Y. et al. Purealin, a novel activator of skeletal muscle actomyosin ATPase and myosin EDTA-ATPase that enhanced the superprecipitation of actomyosin. Eur. J. Biochem. 167, 1–6 (1987).
Wu, H., Nakamura, H., Kobayashi, J., Ohizumi, Y. & Hirata, Y. Lipopurealins, novel bromotyrosine derivatives with long chain acyl groups, from the marine sponge Psammaplysilla purea. Experientia 42, 855–856 (1986).
Kobayashi, J., Honma, K., Tsuda, M. & Kosaka, T. Lipopurealins D and E and Purealidin H, New Bromotyrosine Alkaloids from the Okinawan Marine Sponge Psammaplysilla purea. J. Nat. Prod. 58, 467–470 (1995).
Ishibashi, M., Tsuda, M., Ohizumi, Y., Sasaki, T. & Kobayashi, J. Purealidin A, a new cytotoxic bromotyrosine-derived alkaloid from the Okinawan marine sponge Psammaplysilla purea. Experientia 47, 299–300 (1991).
Kobayashi, J. et al. Purealidins B and C, new bromotyrosine alkaloids from the okinawan marine sponge psammaplysilla purea. Tetrahedron 47, 6617–6622 (1991).
Tsuda, M., Shigemori, H. & Ishibashi, H. Purealidin D, a new pyridine alkaloid from the okinawan marine sponge psammaplysilla purea. Tetrahedron Lett. 33, 2597–2598 (1992).
Tsuda, M., Shigemori, H., Ishibashi, M. & Kobayashi, J. Purealidins E-G, New Bromotyrosine Alkaloids from the Okinawan Marine Sponge Psammaplysilla purea. J. Nat. Prod. 55, 1325–1327 (1992).
Tabudravu, J. N. & Jaspars, M. Purealidin S and Purpuramine J, Bromotyrosine Alkaloids from the Fijian Marine Sponge Druinella sp. J. Nat. Prod. 65, 1798–1801 (2002).
Roll, D. M. et al. Structure of the psammaplysins. J. Am. Chem. Soc. 107, 2916–2920 (1985).
Yagi, H., Matsunaga, S. & Fusetani, N. Purpuramines A-I, new bromotyrosine-derived metabolites from the marine sponge Psammaplysilla purpurea. Tetrahedron 49, 3749–3754 (1993).
Jurek, J., Yoshida, W. Y., Scheuer, P. J. & Kelly-Borges, M. Three New Bromotyrosine-Derived Metabolites of the Sponge Psammaplysilla purpurea. J. Nat. Prod. 56, 1609–1612 (1993).
Carney, J. R., Scheuer, P. J. & Kelly-Borges, M. A New Bastadin from the Sponge Psammaplysilla purpurea. J. Nat. Prod. 56, 153–157 (1993).
Longeon, A., Guyot, M. & Vacelet, J. Araplysillins-I and-II: biologically active dibromotyrosine derivatives from the sponge Psammaplysilla Arabica. Experientia. 46, 548 (1990).
Arabshahi, L. & Schmitz, F. J. Brominated tyrosine metabolites from an unidentified sponge. J. Org. Chem. 52, 3584–3586 (1987).
Acknowledgements
This work was supported in part by the New Energy and Industrial Technology Development Organization of Japan (NEDO) and by a Grant-in-Aid for Scientific Research (20380070 to KS) from The Japan Society for the Promotion of Science (JSPS).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Fujiwara, T., Hwang, JH., Kanamoto, A. et al. JBIR-44, a new bromotyrosine compound from a marine sponge Psammaplysilla purpurea. J Antibiot 62, 393–395 (2009). https://doi.org/10.1038/ja.2009.49
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ja.2009.49
Keywords
This article is cited by
-
JBIR-31, a new teleocidin analog, produced by salt-requiring Streptomyces sp. NBRC 105896 isolated from a marine sponge
The Journal of Antibiotics (2010)
-
Isolation of two new terpeptin analogs—JBIR-81 and JBIR-82—from a seaweed-derived fungus, Aspergillus sp. SpD081030G1f1
The Journal of Antibiotics (2010)
-
Isolation of 2 new metabolites, JBIR-74 and JBIR-75, from the sponge-derived Aspergillus sp. fS14
The Journal of Antibiotics (2010)